Leiden (The Netherlands, 01.07.2021) – As of 1 July 2021, the Supervisory Board of the HAL Allergy Group has appointed Alex Huybens as Chief Executive Officer (CEO) and Member of the Board of HAL Allergy Holding B.V., as well as CEO of HALIX B.V.
Telephone counseling for all hospital staff members in the regions of Lombardei, Emilia Romagna, Veneto, Piedmont
Rome, Italy, (March 26, 2020) – Today, HAL Allergy S.r.l. announced the start of its ‘Prima Linea’ initiative offering telephone counseling for the highly committed hospital staff, who are engaged in the daily fight with the coronavirus in the most affected regions of Italy.
We are very pleased to announce that the Supervisory Board has appointed Dr. Hans van Schijndel as Member of the Board of HAL Allergy Holding B.V. in the position of Chief Research & Development Officer (Chief R&D Officer) as of 1 February 2020.
Leiden, the Netherlands (June 27, 2019) – We are very proud that our CEO Dr. Harry Flore, has been honoured by His Majesty the King of the Netherlands for his…
Registration of SUBLIVAC® Birch and SUBLIVAC® Trees 40.000 AUN/ml in Germany accomplished
Leiden, the Netherlands (14 August 2018) – HAL Allergy B.V. today announced the registration of SUBLIVAC® Birch 40.000 AUN/ml and SUBLIVAC® Trees 40.000 AUN/ml in Germany. These are the first marketing authorisations granted by the Paul Ehrlich Institute following the German Therapieallergene‑Verordnung (TAV).
Wiesbaden, October 7, 2017 – On the occasion of the 12th German Allergy Congress in Wiesbaden, Germany, from October 5th to 7th , 2017, the Internet platform of myAllergy (www.allergy.de) has been awarded with the Digital Health Heroes Award 2017. Every third German is confronted with an issue of allergy in the course of his or her life. According to current scientific predictions, the trend continues to rise. “On the one hand the research and development of new, safe allergy treatments has made great strides forward in the past few decades. On the other hand, those affected often have inadequate knowledge of allergic diseases and the correct methods of treatment options” reports Prof. Dr. Ludger Klimek, Congress President and President of the Medical Association of German Allergists AeDA. The information platform myAllergy can solve this problem and contribute to lead affected people to qualified therapy by physicians specialized in allergies in an earlier stage.